New therapy delays progression of recurrent prostate cancer
- medicalxpress.com language
- 2025-09-29 03:00 event
- 3 hours ago schedule

Domain EYEION.com for sale! This premium domain is available now at Kadomain.com
“I don’t know that I have ever heard a celebrity talk about a hot flash in the moment. Thank you for being so real.”View Entire Post ›
The Embryolisse Lait-Crème Concentré is a multi-tasking hidden gem of a facial cream.View Entire Post ›
After the model opened up about her experience being diagnosed with type 1 diabetes, we asked experts about the autoimmune condition, the differences between type 1 and type 2 diabetes, and how this diagnosis can change your life.View Entire Post ›
An acupuncturist explains how this scary-looking acupressure mat can help relieve back pain.View Entire Post ›
Injuries occurring to people who ride e-scooters cost Irish hospitals an average of €1,726 per patient, and researchers have calculated the total overall cost to one hospital in a single year was €128,650.
Hypnosis can significantly improve patients' tolerance of masks to help them breathe when they are suffering from acute respiratory failure, according to a pilot study presented at the European Emergency Medicine Congress.
People who have obstructive sleep apnea (OSA) may suffer worse symptoms if they live in areas with higher levels of air pollution, according to a multi-national study presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands.
The first detailed analysis of unplanned births that occurred outside the hospital setting in Austria has shown that, although such deliveries are rare, they pose challenges for emergency teams that attend, especially if babies are born prematurely.
People whose fathers smoked during puberty seem to age faster than expected, according to research presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands.
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT) went more than twice as long without their disease worsening compared with those who received SBRT alone, according to new clinical trial results from UCLA Health Jonsson Comprehensive Cancer Center researchers.
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery—the first predictive biomarker in this setting.
A single course of low-dose radiation therapy may provide a safe and effective alternative treatment option for people with painful knee osteoarthritis according to a new randomized, placebo-controlled clinical trial.
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a radiopharmaceutical drug before targeted radiation, compared with radiation alone.
A new academic report from Abertay University and the University of the West of Scotland has highlighted challenges affecting physical activity in Scotland and calls for changes to the policy and funding landscape.
Chagas' disease, also known as the "kissing bug disease," is classified as endemic in 21 countries in the Americas.
Diabetes mellitus—known to many as type 1 and type 2 diabetes—gets all the attention with its rising global prevalence and connection to lifestyle and autoimmunity. Meanwhile, its lesser-known relative—diabetes insipidus—more quietly affects hundreds of thousands of people worldwide, but is an altogether different condition, unrelated to blood sugar.
Children with asthma who use at-home monitoring are around half as likely to visit the emergency department or be hospitalized, compared to those who only receive care from their medical team, according to research presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands. Remote monitoring also helped keep children's symptoms under control.
Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a gold-standard randomized-controlled trial presented at the European Respiratory Society Congress in Amsterdam, the Netherlands.
In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be more effective than salbutamol, the current standard for asthma symptom relief in children, with no additional safety concerns.